• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 79 of 100
Losses mount for U.S. stocks.
Finance
This Pharma Company’s Stock Is Popping for No Clear Reason
By Sy MukherjeeApril 7, 2016
Johns Hopkins Hospital Continues Cancer Research And Treatment
Health
Cancer Treatment Costs Aren’t Rising as Fast as You Thought
By Laura LorenzettiApril 6, 2016
Over 400 Marijuana Stores Ordered To Close As City Regulates Industry
Retail
The DEA Will Soon Decide Whether it Will Reschedule Marijuana
By Tom Huddleston Jr.April 6, 2016
External Insulin Pump
Health
Lifesaving Diabetes Drug Price Tripled in 10 Years
By TIME and Alexandra SifferlinApril 6, 2016
Inside of a Gilead Sciences Lab
Health
The FDA Just Approved Another Next-Gen Gilead HIV Drug
By Sy MukherjeeApril 5, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Finance
This Is Why Valeant’s Shares Are Soaring
By Lucinda ShenApril 5, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Health
Sex Doesn’t Sell: Valeant Cutting Its ‘Female Viagra’ Sales Force
By ReutersApril 5, 2016
DNA genetic testing (crop)
Health
GlaxoSmithKline Is One Step Closer to EU Approval for Its Gene Therapy
By Sy MukherjeeApril 4, 2016
Makers Took Big Price Increases on Widely Used U.S. Drugs
Health
Makers Took Big Price Increases on Widely Used U.S. Drugs
By ReutersApril 4, 2016
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange
Health
Samsung’s Drug Group Is Taking AbbVie to Court in Biotech Copycat Push
By ReutersApril 4, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
Health
Novartis Takes Entresto Case to U.S. Cardiologist Meeting
By ReutersApril 2, 2016
Doctors Without Borders Protests High Cost Of Vaccines
Finance
Pfizer Just Got Pranked Big Time Before April Fool’s Day Even Started
By Jen WiecznerMarch 31, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance
Bill Ackman Can’t Sell Valeant Even If He Wants To
By Lucinda ShenMarch 31, 2016
483106863
Health
GlaxoSmithKline Is Expanding Drug Access to the World’s Poorest Countries
By Sy MukherjeeMarch 31, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Health
Watchdog Says U.S. Big Pharma Isn’t Paying Enough for Breaking the Law
By ReutersMarch 31, 2016
1...
  • 77
  • 78
  • 79
  • 80
  • 81
...100
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Personal Finance
Current price of oil as of July 1, 2026placeholder alt text
By Joseph HostetlerJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.